Project Grant R34CA304591
Award Date 9/11/25
Completion Date 8/31/28
Dollars Obligated $906K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $395,248.00 to Virginia Polytechnic Institute & State University (Virginia Tech) to conduct research on "Generalized and Cancer-Related Episodic Future Thinking for Smoking Cessation: Proof-of-Concept and Feasibility Testing." The research aims to develop an intervention using episodic future thinking to shift smokers' time perspective and reduce their bias...
- The National Cancer Institute (NCI) awarded a $399,891 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Sensewhy, Inc. (UEI: N7FTT2U8NHX7) to evaluate the feasibility and clinical utility of the "Smokemon" wearable device for detecting smoking topography and predicting smoking lapses among cancer survivors who are daily smokers. The project will involve a one-week pre-quit observation period and a four-week post-quit observation period, during which...
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $316,873 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop and evaluate a Spanish-language mobile health (mHealth) smoking cessation app. The goal is to extend the reach of the team's previously validated printed smoking cessation intervention for Hispanic/Latinx smokers, a population disproportionately impacted by smoking-related...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- This federal Project Grant award, in the amount of $798,473, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to develop and evaluate a brief, web-based intervention called Regulation of Craving Training (ROC-T) for smoking cessation. The project aims to test two versions of ROC-T - one focused on reappraisal skills and one on mindfulness-based acceptance - as a preparation intervention to be...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $431,643 Project Grant to The Research Foundation for the State University of New York (RF SUNY) to develop and test a telehealth-delivered, pain-targeted motivational smoking cessation intervention for smokers with chronic pain who are not ready to quit. The project aims to overcome barriers to in-person treatment by delivering the intervention via telehealth in a Stage 1...